AYURCANN REPORTS FISCAL YEAR 2025 RECORD SALES OF $55,446,352 IN GROSS REVENUE, FEATURING 21% YEAR-OVER-YEAR INCREASE AND PROVIDES CORPORATE UPDATE

Core Insights - Ayurcann Holdings Corp. has reported strong financial and operational results for the fiscal year ended June 30, 2025, highlighting its growth and market position in the Canadian cannabis industry [1][5]. Financial Highlights - Gross revenue reached CAD 55,446,352 for the fiscal year 2025, an increase from CAD 45,265,235 in 2024, reflecting a significant year-over-year growth [8]. - Adjusted EBITDA improved to CAD 507,570, compared to a loss of CAD 352,492 in FY2024, indicating a turnaround in financial performance [8]. Operational Highlights - The product portfolio has expanded to 80 SKUs nationwide, demonstrating the company's commitment to innovation and product diversity [8][9]. - Ayurcann's products are available in over 75% of licensed retail cannabis stores across Canada, showcasing a robust national distribution network [3]. - In Ontario, the largest cannabis market in Canada, Ayurcann has achieved over 80% retail penetration, with products in more than 1,500 licensed stores [4]. Market Position - Ayurcann has maintained a 100% year-over-year sales growth for the past three fiscal years (2021-2024), underscoring its operational strength and market leadership [2]. - The company has established strong relationships with the Ontario Cannabis Store and retail partners, enabling it to capture significant market share [4]. Corporate Update - Ayurcann will voluntarily delist from the OTCQB effective October 30, 2025, while continuing to trade on the Canadian Securities Exchange under the ticker symbol "AYUR" [10].